Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Convertible Debt (2016 - 2019)

Aethlon Medical filings provide 8 years of Convertible Debt readings, the most recent being $892591.0 for Q2 2019.

  • On a quarterly basis, Convertible Debt rose 2.43% to $892591.0 in Q2 2019 year-over-year; TTM through Jun 2019 was $892591.0, a 2.43% increase, with the full-year FY2019 number at $962301.0, up 14.4% from a year prior.
  • Convertible Debt hit $892591.0 in Q2 2019 for Aethlon Medical, down from $962301.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $1.1 million in Q2 2017 to a low of $155229.0 in Q1 2015.
  • Median Convertible Debt over the past 5 years was $698698.0 (2016), compared with a mean of $635930.3.
  • Biggest five-year swings in Convertible Debt: crashed 92.76% in 2015 and later soared 222.19% in 2016.
  • Aethlon Medical's Convertible Debt stood at $434643.0 in 2015, then dropped by 4.66% to $414398.0 in 2016, then skyrocketed by 95.67% to $810866.0 in 2017, then rose by 14.94% to $932014.0 in 2018, then fell by 4.23% to $892591.0 in 2019.
  • The last three reported values for Convertible Debt were $892591.0 (Q2 2019), $962301.0 (Q1 2019), and $932014.0 (Q4 2018) per Business Quant data.